MYHOTELMATCH Stock 20.69% Up Today

(VIANEWS) – The Market ended the session with MYHOTELMATCH (MHM.PA) jumping 20.69% to €0.04 on Wednesday while CAC 40 dropped 0.2% to €7,324.76. MYHOTELMATCH’s last close was €0.03, 14.2% below its 52-week high of €0.03. About MYHOTELMATCH MyHotelMatch S.A. engages in the development and exploitation of an online hotel reservation platform based on Artificial Intelligence…

Read More

INTEXA Stock Was 18.7% Up Today

(VIANEWS) – The Market ended the session with INTEXA (ITXT.PA) jumping 18.7% to €2.92 on Wednesday while CAC 40 dropped 0.2% to €7,324.76. About INTEXA Intexa S.A. engages in the operation of the photovoltaic installation in Saint-André-de-Cubzac, France. The company was founded in 2011 and is headquartered in Saint-Etienne, France. Intexa S.A. is a subsidiary…

Read More

DBV TECHNOLOGIES Stock Impressive Rise On Wednesday, Outperforms Market

(VIANEWS) – The Market ended the session with DBV TECHNOLOGIES (DBV.PA) rising 10.27% to €3.31 on Wednesday while CAC 40 fell 0.2% to €7,324.76. DBV TECHNOLOGIES’s last close was €3.00, 45.26% under its 52-week high of €5.48. About DBV TECHNOLOGIES DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous…

Read More

SODITECH Stock Impressive Jump On Tuesday, Outperforms Market

(VIANEWS) – The Market ended the session with SODITECH (SEC.PA) jumping 11.61% to €1.73 on Tuesday while CAC 40 dropped 0.46% to €7,339.27. About SODITECH Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment,…

Read More

POXEL Stock Was 34.96% Up On Tuesday

(VIANEWS) – The Market ended the session with POXEL (POXEL.PA) rising 34.96% to €0.94 on Tuesday while CAC 40 slid 0.46% to €7,339.27. POXEL’s last close was €0.70, 78.71% below its 52-week high of €3.28. About POXEL Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases….

Read More